Veterinary Endocrinology Market Growth, Size, Trends, Analysis- By Animal Type, By Application, By Route of Administration - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Veterinary Endocrinology Market Introduction and Overview

According to SPER Market Research, 'Global Veterinary Endocrinology Market Size By Animal Type, By Application, By Route of Administration - Regional Outlook, Competitive Strategies and Segment Forecast to 2033,' The Global Veterinary Endocrinology Market is projected to achieve a valuation of approximately USD 602.96 million by 2033, experiencing a compound annual growth rate (CAGR) of 7.08%.

The area of veterinary medicine that focuses on the investigation, diagnosis, and management of hormone-related problems in animals is called veterinary endocrinology. The primary objective of this field is to comprehend the endocrine system, which consists of the pituitary, thyroid, adrenal glands, and papillary. Among other body processes, these glands create hormones that control development, metabolism, reproduction, and stress reactions. For example, veterinary endocrinologists diagnose diabetes mellitus, Cushing's disease, Addison's disease, hypothyroidism, and hyperthyroidism in animals.

Impact of COVID-19: The global market for veterinary endocrinology has been significantly impacted by the COVID-19 epidemic, both directly and indirectly. Many hospitals and veterinary clinics had difficulties during the outbreak due to lockdowns, social distancing measures, and a decrease in non-emergency procedures. Delays in diagnosing and treating hormone-related disorders in animals resulted from a decrease in veterinary consultations, especially for endocrine-related issues.

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Animal Type, By Application, By Route of Administration

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Dechra Pharmaceuticals PLC; Boehringer Ingelheim; Elanco; Merck & Co., Inc.; Zoetis; LLOYD, Inc.

Veterinary Endocrinology Market Segmentation:

By Animal Type: Based on the Animal Type, Global Veterinary Endocrinology Market is segmented as; Dogs, Cats, Other Animals.

By Application: Based on the Application, Global Veterinary Endocrinology Market is segmented as; Pancreatic, Disorders, Other Disorders.

By Route of Administration: Based on the Route of Administration, Global Veterinary Endocrinology Market is segmented as; Pancreatic Oral, Other Routes Disorders, Other Disorders

By Region: This research also include data for North America, Europe, Asia-Pacific Middle East & Africa and South America.

Product Code: HLCA24105

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Veterinary Endocrinology Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Veterinary Endocrinology Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Veterinary Endocrinology Market

7. Global Veterinary Endocrinology Market, By Animal Type (USD Million) 2020-2033

7.1. Global Veterinary Endocrinology Market Size, Share and Forecast, By Animal Type, 2020-2026
7.2. Global Veterinary Endocrinology Market Size, Share and Forecast, By Animal Type, 2027-2033
7.3. Dogs
7.4. Cats
7.5. Other Animals

8. Global Veterinary Endocrinology Market, By Application (USD Million) 2020-2033

8.1. Global Veterinary Endocrinology Market Size, Share and Forecast, By Application, 2020-2026
8.2. Global Veterinary Endocrinology Market Size, Share and Forecast, By Application, 2027-2033
8.3. Pancreatic Disorders
8.4. Other Disorders

9. Global Veterinary Endocrinology Market, By Route of Administration (USD Million) 2020-2033

9.1. Global Veterinary Endocrinology Market Size, Share and Forecast, By Route of Administration, 2020-2026
9.2. Global Veterinary Endocrinology Market Size, Share and Forecast, By Route of Administration, 2027-2033
9.3. Pancreatic Oral
9.4. Other Routes Disorders
9.5. Other Disorders

10. Global Veterinary Endocrinology Market Forecast, 2020-2033 (USD Million)

10.1. Global Veterinary Endocrinology Market Size and Market Share

11. Global Veterinary Endocrinology Market, By Region, 2020-2033 (USD Million)

11.1. Global Veterinary Endocrinology Market Size and Market Share By Region (2020-2026)
11.2. Global Veterinary Endocrinology Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
- 11.3.1. Australia
- 11.3.2. China
- 11.3.3. India
- 11.3.4. Japan
- 11.3.5. South Korea
- 11.3.6. Rest of Asia-Pacific
11.4. Europe
- 11.4.1. France
- 11.4.2. Germany
- 11.4.3. Italy
- 11.4.4. Spain
- 11.4.5. United Kingdom
- 11.4.6. Rest of Europe
11.5. Middle East and Africa
- 11.5.1. Kingdom of Saudi Arabia
- 11.5.2. United Arab Emirates
- 11.5.3. Qatar
- 11.5.4. South Africa
- 11.5.5. Egypt
- 11.5.6. Morocco
- 11.5.7. Nigeria
- 11.5.8. Rest of Middle-East and Africa
11.6. North America
- 11.6.1. Canada
- 11.6.2. Mexico
- 11.6.3. United States
11.7. Latin America
- 11.7.1. Argentina
- 11.7.2. Brazil
- 11.7.3. Rest of Latin America

12. Company Profile

12.1. Dechra Pharmaceuticals PLC
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Elanco
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Merck & Co., Inc.
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Boehringer Ingelheim
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. ZoetisL
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. LLOYD, Inc.
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Others